Detalhe da pesquisa
1.
Influence of training and expertise on deep neural network attention and human attention during a medical image classification task.
J Vis
; 24(4): 6, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587421
2.
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.
Gut
; 72(3): 443-450, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008101
3.
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Clin Gastroenterol Hepatol
; 21(13): 3365-3378.e5, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36731588
4.
Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients.
Tech Coloproctol
; 27(6): 501-505, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043102
5.
A Magnetic Resonance Imaging Index to Predict Crohn's Disease Postoperative Recurrence: The MONITOR Index.
Clin Gastroenterol Hepatol
; 20(5): e1040-e1049, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216820
6.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Am J Gastroenterol
; 117(9): 1482-1490, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973142
7.
Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study.
Scand J Gastroenterol
; 57(12): 1454-1462, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819361
8.
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 22(1): 498, 2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36457080
9.
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine.
Clin Gastroenterol Hepatol
; 19(6): 1180-1188.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777552
10.
Tau accumulates in Crohn's disease gut.
FASEB J
; 34(7): 9285-9296, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436623
11.
Expression of CCR6 and CXCR6 by Gut-Derived CD4+/CD8α+ T-Regulatory Cells, Which Are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases.
Gastroenterology
; 155(4): 1205-1217, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981781
12.
Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.
Gastrointest Endosc
; 89(3): 626-636, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120955
13.
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
Gut
; 67(1): 53-60, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28119352
14.
Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
Gut
; 67(4): 616-624, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28115492
15.
The multiple faces of inflammatory enteric glial cells: is Crohn's disease a gliopathy?
Am J Physiol Gastrointest Liver Physiol
; 315(1): G1-G11, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29517926
16.
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission.
Clin Gastroenterol Hepatol
; 16(2): 234-243.e2, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28993262
17.
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
J Autoimmun
; 88: 61-74, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054368
18.
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study.
BMC Gastroenterol
; 23(1): 31, 2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732693
19.
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Gastroenterology
; 150(2): 380-8.e4, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26632520
20.
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Clin Immunol
; 166-167: 1-11, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27050759